Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Healthcare Distribution Market

Healthcare Distribution Market Share

Report ID: GMI9732
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Healthcare Distribution Market Share

The global market for healthcare distribution is highly competitive, driven by technological innovation, increased emphasis on personalized and preventive healthcare, and a rising global aging population. Major players such as McKesson Corporation, Cardinal Health, and AmerisourceBergen dominate the market, leveraging their extensive distribution networks, advanced logistics capabilities, and strong relationships with manufacturers and healthcare providers. Additionally, regional distributors and specialized firms focus on niche segments, such as biologics, specialty drugs, and temperature-sensitive products, to differentiate themselves and meet specific market demands. Companies also focus on sustainability initiatives, aiming to reduce their environmental impact and meet the growing demand for eco-friendly distribution practices.

Healthcare Distribution Market Companies

Some of the eminent market participants operating in the healthcare distribution industry include:

Alliance Healthcare
AmerisourceBergen Corporation
Anda, Inc.
Cardinal Health, Inc.
Celesio AG
CuraScript SD
Henry Schein, Inc.
McKesson Corporation
Medline Industries, Inc.
Morris & Dickson Co., LLC
Owens & Minor, Inc.
Patterson Companies, Inc.
Pheonix Group
Sinopharm Group
Suzuken Co., Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Healthcare distribution industry size was worth USD 1.4 trillion in 2023 and is projected to expand at 7.1% CAGR from 2024 to 2032, owing to the rising prevalence of chronic diseases and the growing aging population.

The pharmaceutical product distribution services type segment in the healthcare distribution industry is estimated to reach USD 1.02 trillion by 2032, due to the growing global population and rising prevalence of chronic diseases.

The retail pharmacies end-use segment in the healthcare distribution industry recorded USD 537.5 billion in 2023 and is projected grow at significant rate from 2024 to 2032, driven by the increasing consumer demand for accessible and convenient healthcare solutions, including prescription and OTC medications.

U.S. healthcare distribution industry is projected to record USD 801.8 billion by 2032, led by the technological developments, regulatory compliance, patient safety concerns, and operational efficiency needs.